EHT0202 in Alzheimers Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study
Bruno Vellas(Centre Hospitalier Universitaire de Toulouse), Matt Pando, Michał Maurin, Robert I. Haddad(Georgetown University), Olivier Sol, P.- J. Snyder, J.-C. Lemarie, Laurent Désiré(HiFiBiO Therapeutics (France)), Pierre‐Jean Ousset
Cited by 128
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer
|New England Journal of Medicine|2007|1.7k
Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2020|1.4k
Recent Advances in Head and Neck Cancer
|New England Journal of Medicine|2008|926